Notice of NICHD Participation in PAR-21-253 "Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)”
Notice Number:
NOT-HD-21-041

Key Dates

Release Date:

August 3, 2021

Related Announcements

PAR-21-253 - Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)

RFA-DK-21-014 - Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions Knowledgebase Management Center (U24 Clinical Trial Not Allowed)

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

This Notice announces the participation of theEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) in PAR-21-253 “Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)", effective immediately.

The following sections of PAR-21-253 have been modified (changes shown in bold italics) to reflect the participation of NICHD in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute of Environmental Health Sciences (NIEHS)

National Cancer Institute (NCI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.847, 93.121, 93.113, 93.855, 93.393, 93.396,93.865

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

NICHD is interested in human studies that address the microbiome and its metabolites in infants who are born preterm or at low birthweights; in child growth and development; in relation to diet and/or nutritional status of children, pregnant individuals or lactating individuals.Additionally, NICHD is interested in the microbiome and its metabolites in gestational diabetes (and risk of gestational diabetes) on pregnancy outcomes and fetal outcomes, and the microbial metabolites of individuals with intellectual or physical disabilities.

Section VII. Agency Contacts

Ashley J, Vargas, PhD, MPH, RDN
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-6030
Email:
ashley.vargas@nih.gov

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Ashley J, Vargas, PhD, MPH, RDN
Eunice Kennedy ShriverNational Institute of Child Health and Human Development (NICHD)
Telephone: 301-827-6030
Email:ashley.vargas@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices